Cargando…

Src Is a Prime Target Inhibited by Celtis choseniana Methanol Extract in Its Anti-Inflammatory Action

Celtis choseniana is the traditional plant used at Korea as a herbal medicine to ameliorate inflammatory responses. Although Celtis choseniana has been traditionally used as a herbal medicine at Korea, no systemic research has been conducted on its anti-inflammatory activity. Therefore, the present...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Han Gyung, Choi, Subin, Lee, Jongsung, Hong, Yo Han, Jeong, Deok, Yoon, Keejung, Yoon, Deok Hyo, Sung, Gi-Ho, Lee, Seungihm, Hong, Suntaek, Yi, Young-Su, Kim, Jong-Hoon, Cho, Jae Youl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872597/
https://www.ncbi.nlm.nih.gov/pubmed/29725354
http://dx.doi.org/10.1155/2018/3909038
_version_ 1783309870080983040
author Kim, Han Gyung
Choi, Subin
Lee, Jongsung
Hong, Yo Han
Jeong, Deok
Yoon, Keejung
Yoon, Deok Hyo
Sung, Gi-Ho
Lee, Seungihm
Hong, Suntaek
Yi, Young-Su
Kim, Jong-Hoon
Cho, Jae Youl
author_facet Kim, Han Gyung
Choi, Subin
Lee, Jongsung
Hong, Yo Han
Jeong, Deok
Yoon, Keejung
Yoon, Deok Hyo
Sung, Gi-Ho
Lee, Seungihm
Hong, Suntaek
Yi, Young-Su
Kim, Jong-Hoon
Cho, Jae Youl
author_sort Kim, Han Gyung
collection PubMed
description Celtis choseniana is the traditional plant used at Korea as a herbal medicine to ameliorate inflammatory responses. Although Celtis choseniana has been traditionally used as a herbal medicine at Korea, no systemic research has been conducted on its anti-inflammatory activity. Therefore, the present study explored an anti-inflammatory effect and its underlying molecular mechanism using Celtis choseniana methanol extract (Cc-ME) in macrophage-mediated inflammatory responses. In vitro anti-inflammatory activity of Cc-ME was evaluated using RAW264.7 cells and peritoneal macrophages stimulated by lipopolysaccharide (LPS), pam3CSK4 (Pam3), or poly(I:C). In vivo anti-inflammatory activity of Cc-ME was investigated using acute inflammatory disease mouse models, such as LPS-induced peritonitis and HCl/EtOH-induced gastritis. The molecular mechanism of Cc-ME-mediated anti-inflammatory activity was examined by Western blot analysis and immunoprecipitation using whole cell and nuclear fraction prepared from the LPS-stimulated RAW264.7 cells and HEK293 cells. Cc-ME inhibited NO production and mRNA expression of inducible nitric oxide synthase (iNOS), cyclooxygenase (COX-2), and tumor necrosis factor-alpha (TNF-α) in the RAW264.7 cells and peritoneal macrophages induced by LPS, pam3, or poly(I:C) without cytotoxicity. High-performance liquid chromatography (HPLC) analysis showed that Cc-ME contained anti-inflammatory flavonoids quercetin, luteolin, and kaempferol. Among those, the content of luteolin, which showed an inhibitory effect on NO production, was highest. Cc-ME suppressed the NF-κB signaling pathway by targeting Src and interrupting molecular interactions between Src and p85, its downstream kinase. Moreover, Cc-ME ameliorated the morphological finding of peritonitis and gastritis in the mouse disease models. Therefore, these results suggest that Cc-ME exerted in vitro and in vivo anti-inflammatory activity in LPS-stimulated macrophages and mouse models of acute inflammatory diseases. This anti-inflammatory activity of Cc-ME was dominantly mediated by targeting Src in NF-κB signaling pathway during macrophage-mediated inflammatory responses.
format Online
Article
Text
id pubmed-5872597
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-58725972018-05-03 Src Is a Prime Target Inhibited by Celtis choseniana Methanol Extract in Its Anti-Inflammatory Action Kim, Han Gyung Choi, Subin Lee, Jongsung Hong, Yo Han Jeong, Deok Yoon, Keejung Yoon, Deok Hyo Sung, Gi-Ho Lee, Seungihm Hong, Suntaek Yi, Young-Su Kim, Jong-Hoon Cho, Jae Youl Evid Based Complement Alternat Med Research Article Celtis choseniana is the traditional plant used at Korea as a herbal medicine to ameliorate inflammatory responses. Although Celtis choseniana has been traditionally used as a herbal medicine at Korea, no systemic research has been conducted on its anti-inflammatory activity. Therefore, the present study explored an anti-inflammatory effect and its underlying molecular mechanism using Celtis choseniana methanol extract (Cc-ME) in macrophage-mediated inflammatory responses. In vitro anti-inflammatory activity of Cc-ME was evaluated using RAW264.7 cells and peritoneal macrophages stimulated by lipopolysaccharide (LPS), pam3CSK4 (Pam3), or poly(I:C). In vivo anti-inflammatory activity of Cc-ME was investigated using acute inflammatory disease mouse models, such as LPS-induced peritonitis and HCl/EtOH-induced gastritis. The molecular mechanism of Cc-ME-mediated anti-inflammatory activity was examined by Western blot analysis and immunoprecipitation using whole cell and nuclear fraction prepared from the LPS-stimulated RAW264.7 cells and HEK293 cells. Cc-ME inhibited NO production and mRNA expression of inducible nitric oxide synthase (iNOS), cyclooxygenase (COX-2), and tumor necrosis factor-alpha (TNF-α) in the RAW264.7 cells and peritoneal macrophages induced by LPS, pam3, or poly(I:C) without cytotoxicity. High-performance liquid chromatography (HPLC) analysis showed that Cc-ME contained anti-inflammatory flavonoids quercetin, luteolin, and kaempferol. Among those, the content of luteolin, which showed an inhibitory effect on NO production, was highest. Cc-ME suppressed the NF-κB signaling pathway by targeting Src and interrupting molecular interactions between Src and p85, its downstream kinase. Moreover, Cc-ME ameliorated the morphological finding of peritonitis and gastritis in the mouse disease models. Therefore, these results suggest that Cc-ME exerted in vitro and in vivo anti-inflammatory activity in LPS-stimulated macrophages and mouse models of acute inflammatory diseases. This anti-inflammatory activity of Cc-ME was dominantly mediated by targeting Src in NF-κB signaling pathway during macrophage-mediated inflammatory responses. Hindawi 2018-03-14 /pmc/articles/PMC5872597/ /pubmed/29725354 http://dx.doi.org/10.1155/2018/3909038 Text en Copyright © 2018 Han Gyung Kim et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Kim, Han Gyung
Choi, Subin
Lee, Jongsung
Hong, Yo Han
Jeong, Deok
Yoon, Keejung
Yoon, Deok Hyo
Sung, Gi-Ho
Lee, Seungihm
Hong, Suntaek
Yi, Young-Su
Kim, Jong-Hoon
Cho, Jae Youl
Src Is a Prime Target Inhibited by Celtis choseniana Methanol Extract in Its Anti-Inflammatory Action
title Src Is a Prime Target Inhibited by Celtis choseniana Methanol Extract in Its Anti-Inflammatory Action
title_full Src Is a Prime Target Inhibited by Celtis choseniana Methanol Extract in Its Anti-Inflammatory Action
title_fullStr Src Is a Prime Target Inhibited by Celtis choseniana Methanol Extract in Its Anti-Inflammatory Action
title_full_unstemmed Src Is a Prime Target Inhibited by Celtis choseniana Methanol Extract in Its Anti-Inflammatory Action
title_short Src Is a Prime Target Inhibited by Celtis choseniana Methanol Extract in Its Anti-Inflammatory Action
title_sort src is a prime target inhibited by celtis choseniana methanol extract in its anti-inflammatory action
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872597/
https://www.ncbi.nlm.nih.gov/pubmed/29725354
http://dx.doi.org/10.1155/2018/3909038
work_keys_str_mv AT kimhangyung srcisaprimetargetinhibitedbyceltischosenianamethanolextractinitsantiinflammatoryaction
AT choisubin srcisaprimetargetinhibitedbyceltischosenianamethanolextractinitsantiinflammatoryaction
AT leejongsung srcisaprimetargetinhibitedbyceltischosenianamethanolextractinitsantiinflammatoryaction
AT hongyohan srcisaprimetargetinhibitedbyceltischosenianamethanolextractinitsantiinflammatoryaction
AT jeongdeok srcisaprimetargetinhibitedbyceltischosenianamethanolextractinitsantiinflammatoryaction
AT yoonkeejung srcisaprimetargetinhibitedbyceltischosenianamethanolextractinitsantiinflammatoryaction
AT yoondeokhyo srcisaprimetargetinhibitedbyceltischosenianamethanolextractinitsantiinflammatoryaction
AT sunggiho srcisaprimetargetinhibitedbyceltischosenianamethanolextractinitsantiinflammatoryaction
AT leeseungihm srcisaprimetargetinhibitedbyceltischosenianamethanolextractinitsantiinflammatoryaction
AT hongsuntaek srcisaprimetargetinhibitedbyceltischosenianamethanolextractinitsantiinflammatoryaction
AT yiyoungsu srcisaprimetargetinhibitedbyceltischosenianamethanolextractinitsantiinflammatoryaction
AT kimjonghoon srcisaprimetargetinhibitedbyceltischosenianamethanolextractinitsantiinflammatoryaction
AT chojaeyoul srcisaprimetargetinhibitedbyceltischosenianamethanolextractinitsantiinflammatoryaction